Company Performance: ONC's financial health, revenue growth, profitability, and debt levels significantly influence its stock price. Strong earnings reports typically lead to price increases.

Industry Trends: The overall performance and outlook of the oncology sector impact ONC.US. Positive industry trends like new drug approvals can boost investor confidence.

Market Sentiment: General investor mood and risk appetite affect all stocks. Economic downturns or market uncertainty can lead to broad sell-offs, impacting ONC.

Regulatory Environment: Changes in healthcare regulations, drug approval processes, or pricing policies can create volatility for ONC.US.

Competition: The presence of competing oncology companies and the emergence of new therapies influence ONC's market share and investor perception.

Clinical Trial Results: Positive outcomes from ONC's clinical trials can significantly increase its stock price, while negative results can have the opposite effect.

Mergers & Acquisitions: Potential or actual mergers, acquisitions, or partnerships involving ONC can create uncertainty and impact the stock price.

Analyst Ratings: Recommendations from financial analysts can sway investor decisions. Upgrades typically lead to price increases, and downgrades can lead to declines.

Economic Conditions: Macroeconomic factors like interest rates, inflation, and GDP growth can influence investor sentiment and the overall stock market.

News & Events: Company-specific news, such as product launches, executive changes, or legal issues, can create short-term fluctuations in the stock price.